KalVista Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
KalVista Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending April 30, 2024 was $6.92M, a 11.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $6.92M -$902K -11.5% Apr 30, 2024 10-K 2024-07-11
Q4 2023 $7.05M -$1.06M -13% Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $7.3M -$1.07M -12.8% Oct 31, 2023 10-Q 2023-12-07
Q2 2023 $7.57M -$1.09M -12.6% Jul 31, 2023 10-Q 2023-09-07
Q1 2023 $7.82M -$40K -0.51% Apr 30, 2023 10-K 2024-07-11
Q4 2022 $8.1M -$79K -0.97% Jan 31, 2023 10-Q 2023-03-09
Q3 2022 $8.37M +$1.41M +20.2% Oct 31, 2022 10-Q 2022-12-08
Q2 2022 $8.66M +$1.46M +20.2% Jul 31, 2022 10-Q 2022-09-08
Q1 2022 $7.86M +$2.1M +36.5% Apr 30, 2022 10-K 2023-07-10
Q4 2021 $8.18M +$6.53M +395% Jan 31, 2022 10-Q 2022-03-10
Q3 2021 $6.96M +$5.65M +433% Oct 31, 2021 10-Q 2021-12-09
Q2 2021 $7.21M +$5.73M +387% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 $5.76M +$4.15M +257% Apr 30, 2021 10-K 2022-07-07
Q4 2020 $1.65M +$156K +10.4% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $1.31M -$329K -20.1% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 $1.48M -$257K -14.8% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $1.61M Apr 30, 2020 10-K 2021-07-13
Q4 2019 $1.5M Jan 31, 2020 10-Q 2020-03-10
Q3 2019 $1.63M Oct 31, 2019 10-Q 2019-12-03
Q2 2019 $1.74M Jul 31, 2019 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.